Reading focus
Syllabus: How Does Substance Use Become Persistent Despite Harm?
Identify the distinct claims carried by the phrase “brain disease,” including claims about mechanism, course and clinical usefulness.
Why you’re reading it. Frame persistence as a problem that needs explanation without assuming one inevitable trajectory.
A question to consider. A person’s use changes substantially after their circumstances change. Which versions of the brain-disease claim would that challenge, and which would remain compatible?
Why this reading
Calling addiction a brain disease can mean several different things. Heilig and colleagues defend a revised account that accommodates variation in course, environmental influences and retained responsiveness to consequences. The argument provides a way to examine what a disease label explains, what it describes and what practical work it is expected to do.
Before you read
A substance use disorder is a classification based on a pattern of problems; physical dependence refers to adaptation that can include withdrawal. Neither is simply a count of how often someone uses a substance. Consilience means bringing explanations at different levels into a coherent account.
Read for
- Separate arguments about the usefulness of a disease category from evidence about the processes producing persistent harmful use.
- Ask which neural findings precede use, follow it or distinguish severity. What would establish a causal contribution?
- Follow the authors’ distinction between a probabilistic influence on choice and an absolute inability to act otherwise.
Consider afterwards
- What observation would challenge a brain-disease account that already allows environmental change and recovery?
- Could two researchers agree on every reported finding but disagree about the most useful explanatory label? Identify their remaining disagreement.
Editorial context
This is a defended position in an ongoing debate, not a neutral statement of consensus. Room’s response questions whether acknowledging neural involvement warrants giving that level explanatory primacy. Neither a brain correlate nor a useful clinical label, by itself, settles that question. The review also cautions against treating every substance-use presentation as inevitably chronic and relapsing.